Alpha 2.0
Login Register
» Authors » Victoria Fornes

Victoria Fornes

Explore the profile of Victoria Fornes including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 24
Followers 0
Related Specialties
General Surgery
Microbiology
Gastroenterology
Top 10 Co-Authors
Joaquim Calvo-Lerma
Carmen Ribes-Koninckx
Etna Masip
Mieke Boon
Kris De Boeck
Carla Colombo
Sandra Woodcock
Maria Garriga
Ine Claes
Ines Asseiceira
Published In
J Cyst Fibros
Transplantation
Rev Iberoam Micol
Nutrients
Rev Esp Enferm Dig
Affiliations
Soon will be listed here.
Recent Articles
1.
N-Acetyl-β-D-Glucosaminidase Analysis in Sheep Milk Can Detect Early Intramammary Infection with High Yields If Incorporated into Mathematical Algorithms
Miralles Y, Fornes V, Roca A, Muelas R, Diaz J, Romero G
Animals (Basel) . 2025 Feb; 15(3). PMID: 39943141
The aim of this study was to analyse the effect of intramammary infection (IMI) on N-acetyl-β-D-glucosaminidase (NAGase) enzyme values and to study its predictive capacity using different algorithms. To do...
2.
Change in Nutrient and Dietary Intake in European Children with Cystic Fibrosis after a 6-Month Intervention with a Self-Management mHealth Tool
Calvo-Lerma J, Boon M, Hulst J, Colombo C, Asseiceira I, Garriga M, et al.
Nutrients . 2021 Jun; 13(6). PMID: 34073260
Cystic Fibrosis (CF) is a life-long genetic disease, causing increased energy needs and a healthy diet with a specific nutrient distribution. Nutritional status is an indicator of disease prognosis and...
3.
Liver Volume as a Predictor of Functional Improvement Post-DAA Treatment
Di Maira T, Torregrosa A, Navarro V, Sanchez D, Fornes V, Berenguer M
Transplantation . 2017 Nov; 102(2):e74-e81. PMID: 29087972
Background: New direct antiviral agents (DAA) for hepatitis C virus treatment result in sustained virologic response (SVR) in most patients. However, predicting the point of no return is still an...
4.
Pancreatic enzyme replacement therapy in cystic fibrosis: dose, variability and coefficient of fat absorption
Calvo-Lerma J, Martinez-Barona S, Masip E, Fornes V, Ribes-Koninckx C
Rev Esp Enferm Dig . 2017 Jul; 109(10):684-689. PMID: 28747058
Objectives: Pancreatic enzyme replacement therapy (PERT) remains a backbone in the nutritional treatment of cystic fibrosis. Currently, there is a lack of an evidence-based tool that allows dose adjustment. To...
5.
[Activity of amphotericin B and anidulafungin, alone and combined, against Candida tropicalis biofilms developed on Teflon and titanium]
Fernandez-Rivero M, Del Pozo J, Valentin A, Fornes V, de Diego A, Peman J, et al.
Rev Iberoam Micol . 2017 Jun; 34(3):175-179. PMID: 28601403
Background: Current therapeutic strategies have a limited efficacy against Candida biofilms that form on the surfaces of biomedical devices. Few studies have evaluated the activity of antifungal agents against Candida...
6.
Nutritional status, nutrient intake and use of enzyme supplements in paediatric patients with Cystic Fibrosis; a European multicentre study with reference to current guidelines
Calvo-Lerma J, Hulst J, Asseiceira I, Claes I, Garriga M, Colombo C, et al.
J Cyst Fibros . 2017 Mar; 16(4):510-518. PMID: 28320633
Background: The New European guidelines have established the most updated recommendations on nutrition and pancreatic enzyme replacement therapy (PERT) in CF. In the context of MyCyFAPP project - a European...